文献速递主动脉外科

急性非复杂性B型主动脉夹层TEVAR与药物治疗中期结局比较

Comparison of mid-term outcomes of endovascular repair and medical management in patients with acute uncomplicated type B aortic dissection.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-12-24

该回顾性队列纳入2008至2018年357例急性非复杂性TBAD患者,倾向性评分匹配后145对分析。TEVAR组早期不良事件更多,但5年全因死亡和主动脉相关死亡更低,晚期破裂累积发生率更低。

核心结论

  • TEVAR虽早期并发症较多,但较BMT降低晚期死亡风险并减少晚期主动脉破裂,或可作为改善晚期结局的首选。

研究设计与样本

  • 回顾性分析2008年2月至2018年3月连续357例急性非复杂性TBAD患者,TEVAR组191例、BMT组166例,倾向性评分匹配后145对。

临床怎么用

  • 对急性非复杂性TBAD,TEVAR虽早期不良事件较多,但可降低晚期死亡和破裂风险,可考虑作为改善晚期结局的首选。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To further assess the early and mid-term outcomes of thoracic endovascular aortic repair (TEVAR) in patients with acute uncomplicated type B aortic dissection (TBAD) compared with those receiving best medical treatment (BMT). METHODS: Between February 2008 and March 2018, 357 consecutive patients with acute uncomplicated TBAD were retrospectively analyzed. Among them, 191 patients underwent TEVAR, and 166 received BMT. After propensity score matching, we obtained 145 matched pairs for analysis. RESULTS: In the matched population, the 30-day mortality between the TEVAR group and the BMT group showed no statistically significant difference, whereas the early adverse events rates in the TEVAR group were significantly greater than that of the BMT group (P = .003). Freedom from all-cause mortality in the TEVAR group was significantly greater than that of the BMT group (TEVAR: 91.9% at 5 years, BMT: 82.2% at 5 years, P = .028). Freedom from aortic-related mortality in the TEVAR group was significantly greater than that of the BMT group (TEVAR: 94.1% at 5 years, BMT: 86.1% at 5 years, P = .044). Multivariable Cox-hazard regression analysis demonstrated that the older age (hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.01-1.08, P = .013), BMT (HR, 2.33; 95% CI, 1.08-5.05, P = .032), and the distance between the primary entry tear and the left subclavian artery <2.0 cm (HR, 2.30; 95% CI, 1.06-4.99, P = .035) were the significant risk factors for all-cause death. Given death as a competing factor, the cumulative incidence of rupture in the BMT group was significantly greater than that of the TEVAR group (BMT: 13.7% at 5 years, TEVAR: 5.1% at 5 years, P = .024). CONCLUSIONS: Despite more complications in the early stage, TEVAR was associated with decreased risk of late death and had fewer late aortic ruptures compared with BMT in patients with acute uncomplicated TBAD. Therefore, TEVAR may be considered as the first option to improve the late outcomes in these patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Xiang D, Kan X, Liang H, et al. Comparison of mid-term outcomes of endovascular repair and medical management in patients with acute uncomplicated type B aortic dissection. J Thorac Cardiovasc Surg. 2019. PMID: 31982125. doi:10.1016/j.jtcvs.2019.11.127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。